Edition:
United States

Profile: Grifols SA (GRLSbn.MC)

GRLSbn.MC on Madrid SE C.A.T.S.

16.70EUR
23 Mar 2017
Change (% chg)

€0.26 (+1.58%)
Prev Close
€16.44
Open
€16.12
Day's High
€16.70
Day's Low
€16.12
Volume
30,573
Avg. Vol
72,250
52-wk High
€17.05
52-wk Low
€12.92

Grifols SA is a Spain-based company engaged in the biopharmaceuticals manufacture. The Company’s activities are divided into four business segments: Bioscience, Hospital, Diagnostic and Raw materials. The Bioscience division focuses on the research, development, manufacturing and marketing of products derived from human plasma for therapeutic use. The Hospital division offers non-biological pharmaceutical products and medical supplies for hospital pharmacy. The Diagnostic division provides clinical analysis and laboratory testing tools to laboratories, hospitals and blood banks. The Raw materials division includes sales of intermediate biological products, as well as manufacturing services to third parties. The Company operates production facilities in Spain, the United States, Mexico and Australia, among others. It controls numerous subsidiaries.

Company Address

Grifols SA

Avinguda de la Generalitat
152, Parque empresarial Can Sant
SANT CUGAT DEL VALLES   BAR   08174
P: +34935.712199
F: +34935.710267

Company Web Links